| Record ID | harvard_bibliographic_metadata/ab.bib.11.20150123.full.mrc:213659798:1770 |
| Source | harvard_bibliographic_metadata |
| Download Link | /show-records/harvard_bibliographic_metadata/ab.bib.11.20150123.full.mrc:213659798:1770?format=raw |
LEADER: 01770cam a2200313Mi 4500
001 011261444-2
005 20071010190909.0
008 070525s2007 gw a 100 0 eng d
016 7 $a983895600$2GyFmDB
020 $a9783540723097 (hd.bd.)
020 $a3540723099 (hd.bd.)
035 0 $aocn137248701
040 $aOHX$cOHX$dBTCTA$dBAKER$dYDXCP$dGSU
072 7 $aHF$2lcco
090 $aHF5387$b.B8726 2007
245 00 $aBusiness ethics of innovation /$cG. Hanekamp (ed.).
260 $aBerlin ;$aNew York :$bSpringer,$cc2007.
300 $axiii, 110 p. :$bill. ;$c24 cm.
490 1 $aEthics of science and technology assessment.,$x1860-4803 ;$vv. 31
500 $aInternational conference proceedings.
504 $aIncludes bibliographical references.
505 0 $aBusiness ethics of innovation : an introduction / Gerd Hanekamp -- Corporate ethics and globalization : global rules and private actors / Horst Steinmann -- Research priorities, profits, and public goods : the case of drug resistant disease / Michael J. Selgelid -- Ethical issues associated with pharmaceutical innovation / Margaret L. Eaton -- Corporate responsibility for innovation : a citizenship framework / Dirk Matten, Andy Crane and Jeremy Moon -- Access to medicines and the innovation dilemma : can pharmaceutical multinationals be good corporate citizens? / Andreas Seiter -- IT innovations & open source : a question of business ethics or business model? / Marcus Nüttgens.
650 0 $aBusiness ethics.
650 0 $aTechnological innovations$xMoral and ethical aspects.
650 0 $aPharmaceutical industry$xMoral and ethical aspects.
700 1 $aHanekamp, Gerd.
830 0 $aWissenschaftsethik und Technikfolgenbeurteilung ;$vBd. 31.
988 $a20071010
906 $0OCLC